Skip to main content
David Wohl, MD, Infectious Disease, Chapel Hill, NC, University of North Carolina Hospitals

DavidAWohlMD

Infectious Disease • Chapel Hill, NC

HIV/AIDS Medicine

Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Wohl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wohl's full profile

Already have an account?

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Infectious Disease, 1994 - 1997
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1991 - 1994
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1991

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1994 - 2024

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • No Evidence of Exponential Increase in ‘AIDS-Associated Diseases and Cancers’ After COVID-19 Vaccine
    No Evidence of Exponential Increase in ‘AIDS-Associated Diseases and Cancers’ After COVID-19 VaccineMay 24th, 2023
  • 2023 Health Care Leadership Awards: Dr. David Alain Wohl – UNC School of Medicine
    2023 Health Care Leadership Awards: Dr. David Alain Wohl – UNC School of MedicineApril 13th, 2023
  • NC COVID Expert: We Still Have Blind Spots in Understanding the Virus. You Can Help
    NC COVID Expert: We Still Have Blind Spots in Understanding the Virus. You Can HelpMarch 1st, 2023
  • Join now to see all

Grant Support

  • RCT Of An Augmented Test, Treat, Link, &Retain Model For NC And Texas PrisonersNational Institute On Drug Abuse2010–2011
  • Incarceration And Hiv-Infected InmatesNational Institute Of Mental Health2007–2010
  • Clinical Trial: Two Doses Of Gw433908/Ritonavir Given With Abacavir/Lamivudine CNational Center For Research Resources2008
  • Clinical Trial: Phase I/II Uridine Supplementation In HIV Lipoatrophy (Actg A522National Center For Research Resources2008
  • Clinical Trial: MRK AD5 HIV-1 GAG Vaccine In HIV-1 Subjects WHO Interupt TherapyNational Center For Research Resources2008
  • Clinical Trial: Enfurvitide (T-20) Intensification For Low Level Viremia (The LoNational Center For Research Resources2008
  • Clinical Trial: A5235 - Minocycline In The Treatment Of Hiv-Associated CognitiveNational Center For Research Resources2008
  • Long-Term Antiviral Management Of HCV And HIV-1 Coinfected Subjects (Slam-C)National Center For Research Resources2006–2008
  • Fat Redistribution And Metabolic Change In HIV InfectionNational Center For Research Resources2005–2008
  • Phase I/II Uridine Supplementation In HIV Lipoatrophy (Actg A5229)National Center For Research Resources2007
  • Phase 3 Comparison Of Lopinavir/Ritonavir Efavirenz Stavudine Lamivudine For IniNational Center For Research Resources2007
  • Enfurvitide (T-20) Intensification For Low Level Viremia (The Lola Study)National Center For Research Resources2007
  • Two Doses Of Gw433908/Ritonavir Given With Abacavir/Lamivudine ComboNational Center For Research Resources2006–2007
  • MRK AD5 HIV-1 GAG Vaccine In HIV-1 Subjects WHO Interupt TherapyNational Center For Research Resources2006–2007
  • Ezetimibe Therapy For Dyslipidemia In Patients Receiving HIV TherapyNational Center For Research Resources2006–2007
  • Nutriceuticals D-Glucarate, Silymarin And Piperine On PharmacokineticsNational Center For Research Resources2005–2007
  • Potent Combination Of Antiretroviral Regimen In African-American Men And WomenNational Center For Research Resources2004–2007
  • Phase II Once-Weekly Alendronate In Hiv-Infected Subjects With Decreased Bone DNational Center For Research Resources2004–2007
  • HIV+ Prison Releases To Access To HIV Care And ServicesNational Institute On Drug Abuse2003–2007
  • Combination Therapy With Fish Oil Supplement And FenofibrateNational Center For Research Resources2005–2006
  • Antiretroviral Switch At Lower VS Higher HIV-1 RNA Levels With RelapseNational Center For Research Resources2005–2006
  • Valganciclovir Pre-Emptive Therapy For CMV Viremia (Actg A5030)National Center For Research Resources2004–2006
  • ACTG A5142National Center For Research Resources2004–2006
  • Potent Combo Antiretroviral Regimen In AA Men And WomenNational Center For Research Resources2005
  • Fish Oil Supplementation PLUS Diet And Excercise VS Diet And Exercise Alone-HivNational Center For Research Resources2005
  • Metformin And Rosiglitazone Alone Or In Combination In Hiv-Infected SubjectsNational Center For Research Resources2004–2005
  • Immune Response To Pneumococcal Vaccine In Patients With HIVNational Center For Research Resources2004–2005
  • Fish Oil Supplementation PLUS Diet And Excercise Vs. Diet And Exercise Alone-HivNational Center For Research Resources2004
  • Combinations Of Potent Antiretroviral Therapy, Hiv-Specific ImmunizationsNational Center For Research Resources2004
  • Antiretroviral Switch At Lower Vs. Higher HIV-1 RNA Levels With RelapseNational Center For Research Resources2004
  • Thalidomide For Treatment Of Recurrent Aphthous Ulcers In HIVNational Center For Research Resources1999–2002
  • NCI AIDS Related Cancer Cohort Study (ACCS)National Center For Research Resources1999–2002
  • Ganciclovir Cidofovir CMV Retinitis TrialNational Center For Research Resources1999–2002
  • ACTG 379 Discontinuing Maintenance Therapy For CMV RetinitisNational Center For Research Resources1999–2002
  • HIV And CMV Viral Burden And Development Of CMV End-Organ DiseaseNational Center For Research Resources1998–2002
  • A Longitudinal Study Of The Predictive Value Of Quantitative CMVNational Center For Research Resources1997–2002
  • Trial Of Salvage Antiretroviral Therapies For HIV PTSNational Center For Research Resources2000
  • The Longitudinal Study Of Ocular Complications Of AIDSNational Center For Research Resources2000
  • Thalidomide For Recurrent Aphthous Stomatitis In HIVNational Center For Research Resources2000
  • HIV &Cmv &Development Of CMV End-Organ DiseaseNational Center For Research Resources2000
  • Ddl/D4t/Hu VS Ddl/D4t/Efv VS Protease Inhibitor In HIV PTSNational Center For Research Resources2000
  • Abt378/Ritonavir W/ Reverse Transcriptase Inhibitors In HIVNational Center For Research Resources2000
  • A Longitudinal Study Of Quantitative CMV In Pys W/ AIDSNational Center For Research Resources2000
  • Investigational New Drug Application For HIVNational Center For Research Resources1998–1999

Hospital Affiliations

Dr. David Wohl, Dr. David Wohl, MD, Dr. D Wohl, Dr. David A Wohl